NCT07275879

Brief Summary

Double-J (DJ) stents are commonly inserted after ureteroscopy. There are several complications associated with the presence of DJ stent: urinary tract infection, stent encrustation, stent migration, and stent-related symptoms (SRS). SRS occur in up to 80% of patients and include pain, hematuria, and dysuria, all of which negatively impact the patient's quality of life. Physicians proposed the distal end of the ureteral stents might involve in SRS by over-simulating the trigone of bladder. The design of the distal end, made with a thinner loop than that of a standard DJ stent, is intended to mitigate SRS and reduce urine reflux.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 10, 2025

Completed
18 days until next milestone

Study Start

First participant enrolled

December 28, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

December 10, 2025

Status Verified

November 1, 2025

Enrollment Period

3 months

First QC Date

November 18, 2025

Last Update Submit

December 8, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • ureteral reflux

    Injection of raradiopaque dye using gravity- filling cystogram followed by X-ray imaging. If contrast entered or not entered the ureter and kidney, ureteral reflux was considered positive or not, respectively.

    Intraoperative

  • Assessment the Ureteral Stent Symptom Questionnaire (USSQ)

    Ureteral stent symptom questionnaire (USSQ) a psychometrically valid measure to evaluate symptoms and impact on quality of life of ureteral stents. USSQ contains 38 questions and 2 visual analog scales (VAS), allowing assessment of the severity of SRS and their impact on the patient's quality of life. The questions are grouped into 6 domains: Urinary symptoms Pain General health Work performance Sexual matters Additional problems For each domain, a score index is calculated as the sum of the points from all questions in that domain. The scale scores range from 1 to 10, with higher values indicating more severe SRS and lower quality of life.

    Postoperative: 1st and 7th day, before stent removal

Secondary Outcomes (5)

  • Patient's height

    Preoperative

  • Patient's weight

    Preoperative

  • Body mass index (BMI)

    Preoperative

  • Operative time

    Intraoperative (measured from start to end of procedure)

  • Surgery

    Preoperative

Study Arms (2)

Group I (DJ stent)

ACTIVE COMPARATOR

Non-prestented patients who will insert a standard DJ stent after surgery

Procedure: Ureteric stent insertion

Group II (modified DJ stent)

EXPERIMENTAL

Non-prestented patients who will insert a modified DJ stent after surgery

Procedure: Ureteric stent insertion

Interventions

Ureteric stent insertion is the procedure to place a thin, flexible plastic tube that is temporarily in the ureter to help urine drain. They are placed with cystoscopic and X-ray guidances in an operating room setting

Group I (DJ stent)Group II (modified DJ stent)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years and older
  • Patients with kidney stones
  • Patients with ureteral stones

You may not qualify if:

  • Congenital anomalies of the urinary tract
  • Urinary tract infections
  • Upper urinary tract obstruction
  • Complicated ureteroscopy (e.g., ureteral perforation)
  • Pregnancy
  • Pre-stented patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Luke's Clinical Hospital

Saint Petersburg, Outside U.S./Canada, Russia

RECRUITING

MeSH Terms

Conditions

Urolithiasis

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Urologist

Study Record Dates

First Submitted

November 18, 2025

First Posted

December 10, 2025

Study Start

December 28, 2025

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

December 10, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

We are currently finalizing our data sharing policy. All required individual participant data underlying the reported results will be made available for regulatory purposes immediately upon request, and may be shared with researchers following publication after de-identification, contingent on submission of a methodologically sound proposal and compliance with institutional and national privacy regulations

Locations